StockData
Aytu BioPharma, Inc logo

Aytu BioPharma, Inc (AYTU) stock

AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.84 (+46.15%)

Close on Nov 17, 2026Market cap $28.91MP/E –Yield –

Aytu BioPharma cash

Cash and short-term investments held at the end of each period.

Aytu BioPharma's cash was $26.31M at Jun 30, 2026. For fiscal 2026 it was $26.31M, down 15.0% from the year before. Over ten years it grew 12.6% a year on average. The highest annual figure on record is $49.90M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026$26.31M-15.0%
FY2025Jun 30, 2025$30.95M+54.7%
FY2024Jun 30, 2024$20.01M-13.0%
FY2023Jun 30, 2023$22.99M+18.7%
FY2022Jun 30, 2022$19.36M-61.2%
FY2021Jun 30, 2021$49.90M+3.2%
FY2020Jun 30, 2020$48.33M+337.6%
FY2019Jun 30, 2019$11.04M+57.5%
FY2018Jun 30, 2018$7.01M+699.1%
FY2017Jun 30, 2017$877.54K-89.1%
FY2016Jun 30, 2016$8.05M+9.5%
FY2015Jun 30, 2015$7.35M+394801.2%
FY2013Aug 31, 2013$1.86K+1608.3%
FY2012Aug 31, 2012$109-97.3%
FY2011Aug 31, 2011$3.99K+158.4%
FY2010Aug 31, 2010$1.55K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$26.31M-15.0%
Q3 FY2026CQ1 2026Mar 31, 2026$26.72M+47.0%
Q2 FY2026CQ4 2025Dec 31, 2025$30.03M+47.2%
Q1 FY2026CQ3 2025Sep 30, 2025$32.63M+62.3%
Q4 FY2025CQ2 2025Jun 30, 2025$30.95M+54.7%
Q3 FY2025CQ1 2025Mar 31, 2025$18.17M-8.0%
Q2 FY2025CQ4 2024Dec 31, 2024$20.40M+4.4%
Q1 FY2025CQ3 2024Sep 30, 2024$20.11M+0.7%
Q4 FY2024CQ2 2024Jun 30, 2024$20.01M-13.0%
Q3 FY2024CQ1 2024Mar 31, 2024$19.76M+3.0%
Q2 FY2024CQ4 2023Dec 31, 2023$19.53M+0.1%
Q1 FY2024CQ3 2023Sep 30, 2023$19.96M-16.2%
Q4 FY2023CQ2 2023Jun 30, 2023$22.99M+18.7%
Q3 FY2023CQ1 2023Mar 31, 2023$19.18M-30.5%
Q2 FY2023CQ4 2022Dec 31, 2022$19.50M-44.7%
Q1 FY2023CQ3 2022Sep 30, 2022$23.81M-40.9%
Q4 FY2022CQ2 2022Jun 30, 2022$19.36M-61.2%
Q3 FY2022CQ1 2022Mar 31, 2022$27.61M-40.7%
Q2 FY2022CQ4 2021Dec 31, 2021$35.28M-43.1%
Q1 FY2022CQ3 2021Sep 30, 2021$40.31M+6.3%
Q4 FY2021CQ2 2021Jun 30, 2021$49.90M+3.2%
Q3 FY2021CQ1 2021Mar 31, 2021$46.54M-25.3%
Q2 FY2021CQ4 2020Dec 31, 2020$62.03M+1079.4%
Q1 FY2021CQ3 2020Sep 30, 2020$37.91M+440.5%
Q4 FY2020CQ2 2020Jun 30, 2020$48.33M+337.6%
Q3 FY2020CQ1 2020Mar 31, 2020$62.26M+325.1%
Q2 FY2020CQ4 2019Dec 31, 2019$5.26M-70.5%
Q1 FY2020CQ3 2019Sep 30, 2019$7.01M+76.9%
Q4 FY2019CQ2 2019Jun 30, 2019$11.04M+57.5%
Q3 FY2019CQ1 2019Mar 31, 2019$14.65M+22.0%
Q2 FY2019CQ4 2018Dec 31, 2018$17.80M+346.9%
Q1 FY2019CQ3 2018Sep 30, 2018$3.96M-44.1%
Q4 FY2018CQ2 2018Jun 30, 2018$7.01M+699.1%
Q3 FY2018CQ1 2018Mar 31, 2018$12.01M+238.7%
Q2 FY2018CQ4 2017Dec 31, 2017$3.98M-24.9%
Q1 FY2018CQ3 2017Sep 30, 2017$7.10M+151.3%
Q4 FY2017CQ2 2017Jun 30, 2017$877.54K–
Q3 FY2017CQ1 2017Mar 31, 2017$3.55M–
Q2 FY2017CQ4 2016Dec 31, 2016$5.31M–
Q1 FY2017CQ3 2016Sep 30, 2016$2.82M–

More Aytu BioPharma figures

See a number that looks wrong?